Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study
Hermine I. Brunner, Grebenkina La, Irina Nikishina, Ekaterina Alexeeva et autres
0 citationsArthritis & Rheumatology